SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?


To: LoLoLoLita who wrote (280)11/30/1997 10:18:00 AM
From: men mailman  Respond to of 2068
 
Thanks for the S&p outlook article great news.

Short interest nov 15th declined 33% form 3.6mm to 2.3mm.

I think the S&P article about oxhp a takeover candidate, and the Dec 5th audit announcement will hopefully bring many more upgrades.

OXHP will double in price in 12-18 months. They are still projecting very healthy growth in 98. They will probably enter new cities in 98 growing the business.

When looking around at other stocks priced in the $24 range I don't have a better potential for a short $10 move and a long $20-25 move with very little downside risk (maybe $2-3) as good as oxhp.